BlueCrest Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-20,163
| Closed | -$1.24M | – | 594 |
|
|
2019
Q2 | $1.24M | Sell |
20,163
-58,137
| -74% | -$3.58M | 0.09% | 128 |
|
|
2019
Q1 | $4.99M | Buy |
+78,300
| New | +$4.99M | 0.2% | 79 |
|
|
2018
Q4 | – | Sell |
-4,284
| Closed | -$249K | – | 1022 |
|
|
2018
Q3 | $249K | Sell |
4,284
-22,500
| -84% | -$1.31M | 0.01% | 1122 |
|
|
2018
Q2 | $1.3M | Sell |
26,784
-399
| -1% | -$19.4K | 0.03% | 415 |
|
|
2018
Q1 | $1.26M | Buy |
+27,183
| New | +$1.26M | 0.04% | 395 |
|
|
2017
Q3 | – | Sell |
-34,137
| Closed | -$1.35M | – | 890 |
|
|
2017
Q2 | $1.35M | Sell |
34,137
-140,415
| -80% | -$5.53M | 0.05% | 394 |
|
|
2017
Q1 | $5.47M | Buy |
+174,552
| New | +$5.47M | 0.26% | 114 |
|
|
2016
Q3 | – | Sell |
-24,870
| Closed | -$827K | – | 769 |
|
|
2016
Q2 | $827K | Buy |
+24,870
| New | +$827K | 0.03% | 375 |
|